After 30 years, an immunotherapy to rival CAR-T finally nears the clinic - STAT

After 30 years, an immunotherapy to rival CAR-T finally nears the clinic - STAT

After 30 years, an immunotherapy to rival CAR-T finally nears the clinic

By SHARON BEGLEY @sxbegle

AUGUST 9, 2018

NATIONAL CANCER INSTITUTE

A new kind of immunotherapy, called TILs, is poised to surpass CAR-Ts in the diversity of cancers they treat — including solid tumors.

READ MORE